⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Lyell Immunopharma, Inc. Common Stock

$14.21
-0.03 (-0.21%)

Market Capitalization:

$348.21M

Lyell Immunopharma Price Chart

Lyell Immunopharma Price Chart2:30 PM3:50 PM5:10 PM6:30 PM7:50 PM5:09 AM6:29 AM14.5014.4414.3714.3114.2514.1814.12

Lyell Immunopharma Volume Chart

Lyell Immunopharma Volume Chart2:30 PM3:50 PM5:10 PM6:30 PM7:50 PM5:09 AM6:29 AM24.21K20.75K17.29K13.83K10.38K6.92K3.46K

Lyell Immunopharma Market Segments

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$14.21
Close$14.21
Low$14.21
Low Change0.00 (0.00%)
High$14.21
High Change+0.00 (+0.00%)
Range$0.00
Volume24.21K
Dollar Volume$344.02K

Regular Trading Hours Yesterday

+0.23(+1.64%)
Open$14.01
Close$14.24
Low$13.85
Low Change-0.16 (-1.14%)
High$15.63
High Change+1.62 (+11.53%)
Range$1.78
Volume330.065K
Dollar Volume$4.70M

Premarket Yesterday

+0.00(+0.00%)
Open$13.70
Close$13.70
Low$13.70
Low Change0.00 (0.00%)
High$13.70
High Change+0.00 (+0.00%)
Range$0.00
Volume464
Dollar Volume$6.36K

Lyell Immunopharma Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Lyell Immunopharma Moving Averages

5 Day Moving Average (SMA5)$13.43
10 Day Moving Average (SMA10)$13.24
20 Day Moving Average (SMA20)$13.42
50 Day Moving Average (SMA50)$13.63
100 Day Moving Average (SMA100)$17.19
200 Day Moving Average (SMA200)$20.55

Lyell Immunopharma Statistics

Average Volume (30 Days)228.27K
P/E Ratio (Current)-1.34
EPS (Current)-$10.06
Dividend Yield0.00%
Free Cash Flow-$134.42M
Cash Ratio2.46
Current Ratio7.23
Quick Ratio7.23
Debt to Equity0.00
Enterprise Value$238.81M
EV to EBITDA-1.32
EV to Sales7703.67
Price to Book1.20
Price to Cash Flow
Price to Free Cash Flow
Price to Sales10631.73
Return on Assets-0.70%
Return on Equity-0.90%

Lyell Immunopharma Stock Splits

There has been 1 stock split for Lyell Immunopharma (LYEL). The reverse stock split occured on June 2, 2025 and reduced the outstanding shares at a ratio of 20:1.

DateTypeRatio
Jun 2, 2025Reverse20:1

Lyell Immunopharma Dividends

There have been no dividends for Lyell Immunopharma (LYEL).